role of interventional radiology in the treatment of...

38
Role of Interventional Radiology in the Treatment of NET Jonathan Kessler, MD Assistant Clinical Professor Division of Interventional Radiology City of Hope Comprehensive Cancer Center

Upload: trinhbao

Post on 29-Jul-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

Role of Interventional

Radiology in the Treatment of NET

Jonathan Kessler, MD

Assistant Clinical Professor

Division of Interventional Radiology

City of Hope Comprehensive Cancer Center

Pavel et al ENETS Consensus Guidleines for the Management of Patients with Liver and

Other Distant Metasases from Neuroendocrine Neoplasms. Neuroendocirnology 2012

California Cancer Registry 2005-2012

Treatments of Hepatic Metastases

Pavel et al ENETS Consensus Guidleines for the Management of Patients with Liver and

Other Distant Metasases from Neuroendocrine Neoplasms. Neuroendocirnology 2012

Feng J Hepatol. 2012 Oct;57(4):794-802.

Chen Ann Surg 2006; 243:321–328

≤ 3 lesions

≤ 3 cm in size

Location amenable to ablation

No ablation modality proven to be better

RFA/Microwave/Cryo…

≤ 3 lesions 5 lesions

≤ 3 cm in size 5 cm in size

Location amenable to ablation

No ablation modality proven to be better

RFA/Microwave/Cryo…

Chamberlain et al. JCAS 2000 Apr; 190

Mayo et al Annals of Surg Onc 2011

Hanssen et al Acta Oncol. 1991;30(4):523-7

Gupta Cancer. 2005 Oct 15;104(8):1590-602

Sward et al Br J Surg. 2009 May;96(5):517-21.

Madoff et al. J Vas Interv Radiol 2006 Aug;17(8):1235-49

DEB - TACE

DEB vs cTACE in HCC (PRECISION V Trial)

Reduced liver toxicity and side effects

SAE: 30.6% vs 20.4%

Alopecia: 19.4% vs 2.2%

Max transaminase change 50% less

Lammer et al. CVIR 2010 33:41-52.

DEB- TACE

Drug eluting bead TACE

Phase II 13 pts treated with doxorubicin beads

ORR 78%

54% biloma formation

4 required drainage

Bhagat et al CVIR 2013

Radioembolization

Yttrium 90 Pure beta-emitter with a

half-life of 64.2 hours.

Tissue penetration of the emissions is 2.5 to 11 mm

Available in two forms Glass (HDE for HCC) and Resin (FDA for CRC)

Delivered via transarterial catheter and emits local high dose of radiation to tumor.

Kennedy et al Am J Clin Onc June 2008

Radioembolization

Yang et al Surgical Oncology 2012